# Patient‐reported outcome results in patients with type 2 diabetes treated with once‐weekly dulaglutide: data from the <scp>AWARD</scp> phase <scp>III</scp> clinical trial programme

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/patient-reported-outcome-results-in-patients-with-type-2-diabetes-treated-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Miao Yu,Kate Van Brunt,Oralee J. Varnado,Kristina S. Boye |
| Citations | 27 |
| DOI | 10.1111/dom.12624 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2207970920 |
| PMID | 26691396 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Oralee J. Varnado](https://scholariq.org/researchers/oralee-j-varnado/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.